Aurobindo: Biosimilars Inflection Point Pushed, gPomalyst Launch Set For Q4

China-Led Fall In Pen-G, 6-APA Prices

 
• By Vibha Ravi
  
Aurobindo Confident On Biosimilars But Recalibrates Inflection Point
Aurobindo Confident On Biosimilars But Recalibrates Inflection Point (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business